Inventor · disambiguated record
Arun Srivastava
Also filed as: SRIVASTAVA ARUN
28 granted patents·23 pending applications·1,346 citations·filing 1991–2024
98Inventor score
Files withUNIV FLORIDA42CHIRON CORP3RES CORP TECHNOLOGIES INC2ADVANCED RES & TECH INST1OSTROV DAVID A1
Top patents by PatentIndex Score
51 records- 0198US9775918B2Capsid-modified rAAV vectors and methods of useUNIV FLORIDA·Filed 2015·Granted Oct 3, 2017·48 cites·23 claims
- 0298US8802440B2Therapeutic methods based on tyrosine-substituted, capsid-modified rAAV vectorsUNIV FLORIDA·Filed 2013·Granted Aug 12, 2014·37 cites·20 claims
- 0398US5252479ASafe vector for gene therapyRES CORP TECHNOLOGIES INC·Filed 1991·Granted Oct 12, 1993·679 cites·16 claims
- 0497US9920097B2Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of useUNIV FLORIDA·Filed 2013·Granted Mar 20, 2018·31 cites·10 claims
- 0597US9725485B2AAV vectors with high transduction efficiency and uses thereof for gene therapyUNIV FLORIDA·Filed 2013·Granted Aug 8, 2017·62 cites·28 claims
- 0697US9611302B2High-transduction-efficiency RAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2013·Granted Apr 4, 2017·67 cites·20 claims
- 0797US9157098B2Transduction efficiency, capsid-modified rAAV vectors and methods of useUNIV FLORIDA·Filed 2013·Granted Oct 13, 2015·33 cites·23 claims
- 0896US10723768B2Capsid modified rAAV vectors and methods of useUNIV FLORIDA·Filed 2017·Granted Jul 28, 2020·9 cites·31 claims
- 0996US10426844B2Capsid-mutated rAAV vectors and methods of useUNIV FLORIDA·Filed 2016·Granted Oct 1, 2019·24 cites·10 claims
- 1096US10294281B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2017·Granted May 21, 2019·21 cites·19 claims
- 1196US10011640B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2014·Granted Jul 3, 2018·42 cites·14 claims
- 1295US12065467B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2022·Granted Aug 20, 2024·2 cites·21 claims
- 1395US11034974B2Hairpin MRNA elements and methods for the regulation of protein translationUNIV FLORIDA·Filed 2018·Granted Jun 15, 2021·9 cites·22 claims
- 1495US10934327B2Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancerUNIV FLORIDA·Filed 2017·Granted Mar 2, 2021·6 cites·21 claims
- 1595US10815279B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2018·Granted Oct 27, 2020·10 cites·19 claims
- 1695US10308957B2rAAV vectors and methods for transduction of photoreceptors and RPE cellsUNIV FLORIDA·Filed 2015·Granted Jun 4, 2019·13 cites·8 claims
- 1795US8445267B2Tyrosine-modified recombinant rAAV vector compositions and methods for useZHONG LI·Filed 2008·Granted May 21, 2013·44 cites·20 claims
- 1893US10927150B2Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2019·Granted Feb 23, 2021·5 cites·17 claims
- 1991US12358954B2Capsid-modified rAAV vector compositions and methods thereforUNIV FLORIDA·Filed 2022·Granted Jul 15, 2025·1 cites·20 claims
- 2090US11434260B2High-transduction-efficiency rAAV vectors, compositions, and methods of useUNIV FLORIDA·Filed 2019·Granted Sep 6, 2022·3 cites·21 claims
- 2190US11124544B2AAV vectors with high transduction efficiency and uses thereof for gene therapyUNIV FLORIDA·Filed 2017·Granted Sep 21, 2021·4 cites·32 claims
- 2290US10006049B2Hairpin mRNA elements and methods for the regulation of protein translationUNIV FLORIDA·Filed 2014·Granted Jun 26, 2018·7 cites·23 claims
- 2390US6261834B1Vector for gene therapyRES CORP TECHNOLOGIES INC·Filed 1992·Granted Jul 17, 2001·102 cites·15 claims
- 2486US6521225B1AAV vectorsCHIRON CORP·Filed 1997·Granted Feb 18, 2003·57 cites·6 claims
- 2583US10900053B2Genome-modified recombinant adeno-associated virus vectorsUNIV FLORIDA·Filed 2015·Granted Jan 26, 2021·2 cites·30 claims
- 2680US2024109938A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2023·Application pending·0 cites
- 2779US8492344B2PDK inhibitor compounds and methods of use thereofOSTROV DAVID A·Filed 2009·Granted Jul 23, 2013·2 cites·11 claims
- 2877US2025369014A9Site-specific integrating recombinant aav vectors for gene therapy and improved production methodsUNIV FLORIDA·Filed 2024·Application pending·0 cites
- 2975US2021040156A1Capsid-modified raav vectors and methods of useUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 3073US2016333372A1Capsid-modified, raav3 vector compositions and uses in gene therapy of human liver cancerUNIV FLORIDA·Filed 2014·Application pending·0 cites
- 3172US2021269487A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3271US2018244727A1Capsid-modified raav vector compositions having improved transduction efficiencies, and methods of useUNIV FLORIDA·Filed 2018·Application pending·0 cites
- 3370US11266748B2Recombinant adeno-associated virus vectors to target medullary thyroid carcinomaUNIV FLORIDA·Filed 2016·Granted Mar 8, 2022·1 cites·20 claims
- 3465US2022347317A1Aavrh74 vectors for gene therapy of muscular dystrophiesUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 3564US2024181083A1Aavrh74 vectors for gene therapy of muscular dystrophiesUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 3664US2021189428A1Genome-modified recombinant adeno-associated virus vectorsUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3763US2019127424A1Capsid-modified raav vector compositions and methods thereforUNIV FLORIDA·Filed 2018·Application pending·0 cites
- 3862US7052692B1Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expressionADVANCED RES & TECH INST·Filed 1998·Granted May 30, 2006·25 cites·35 claims
- 3961US2022233719A1Recombinant adeno-associated virus vectors to target medullary thyroid carcinomaUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 4060US2018030096A1Recombinant aav1, aav5, and aav6 capsid mutants and uses thereofUNIV FLORIDA·Filed 2016·Application pending·0 cites
- 4159US2024398991A1Aavrh74 particles for gene therapy of muscle diseaseUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 4259US2025121094A1Aav particles with modified inverted terminal repeats for enhanced gene expression in muscleUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 4355US2024209393A1Synthetic aav vectors for repeated delivery of therapeutic genesUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 4454US2003166284A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2002·Application pending·0 cites
- 4553US2021205382A1Methods and compositions for using metal elements in aav gene therapyUNIV OF FLORIDA RESEARCH FOUNDATION INCORPORATION·Filed 2019·Application pending·0 cites
- 4652US2001051611A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2001·Application pending·0 cites
- 4750US2023233708A1Enhancing aav-mediated delivery and transduction with polyvinyl alcoholUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 4850US2018044698A1Site-specific integrating recombinant aav vectors for gene therapy and improved production methodsUNIV FLORIDA·Filed 2016·Application pending·0 cites
- 4949US2022227875A1Vector-based therapy for thyroid diseaseUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 5045US2022186258A1Modified aav vectors that dampen the humoral immune responseUNIV FLORIDA·Filed 2020·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arun Srivastava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →